Altimmune
Develops peptide-based therapeutics for obesity and liver diseases.
BiotechnologyPharmaceuticals
Company facts
- Founded
- 1997
- Employees
- 59
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: ALT
- Subsidiaries
- Altimmune LLC, Altimmune UK Limited, Spitfire Pharma LLC, Altimmune AU Pty Limited